Drug Discovery

Ensuring that options for patients living with rare diseases aren’t scarce.

New approaches are underway for treating nonalcoholic steatohepatitis.

Sitting down with Janssen's David Lee to discuss a new era in immunology R&D.

Can prodrug payloads lead to a new dawn for antibody drug conjugates?

We curate the COVID-19 news and breakthroughs of 2020 to bring you a helicopter view of the global fight against COVID-19.

Exploring the role of the gut microbiome on immunotherapy.

Sitting Down With... Anne Phelan, Chief Scientific Officer at BenevolentAI.

Sanofi and DNDi are co-developing a drug – acoziborole – to treat sleeping sickness.

Oligonucleotide-based therapeutics present manufacturers with specific processing and characterization challenges.

Novo Nordisk's Stephen Gough explains how pharma can address the cardiovascular risks associated with type 2 diabetes.